메뉴 건너뛰기




Volumn 160, Issue 3, 2016, Pages 372-377

The long-term effects of probiotics in the therapy of ulcerative colitis: A clinical study

Author keywords

Bifidobacteria; Inflammatory bowel diseases; Lactobacilli; Microbiota; Ulcerative colitis

Indexed keywords

MESALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT; PROBIOTIC AGENT;

EID: 84988489491     PISSN: 12138118     EISSN: 18047521     Source Type: Journal    
DOI: 10.5507/bp.2016.044     Document Type: Article
Times cited : (99)

References (37)
  • 3
    • 34547176642 scopus 로고    scopus 로고
    • Unravelling the pathogenesis of inflammatory bowel disease
    • Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-34.
    • (2007) Nature , vol.448 , pp. 427-434
    • Xavier, R.J.1    Podolsky, D.K.2
  • 4
    • 46649120083 scopus 로고    scopus 로고
    • Intestinal mucosa-associated microflora in ulcerative colitis patients before and after restorative proctocolectomy with an ileoanal pouch
    • Almeida MG, Kiss DR, Zilberstein B, Quintanilha AG, Teixeira MG, Habr-Gama A. Intestinal mucosa-associated microflora in ulcerative colitis patients before and after restorative proctocolectomy with an ileoanal pouch. Dis Colon Rectum 2008;51:1113-9.
    • (2008) Dis Colon Rectum , vol.51 , pp. 1113-1119
    • Almeida, M.G.1    Kiss, D.R.2    Zilberstein, B.3    Quintanilha, A.G.4    Teixeira, M.G.5    Habr-Gama, A.6
  • 5
    • 84872687670 scopus 로고    scopus 로고
    • Inflammation-associated entero-types, host genotype cage and inter-individual effects drive gut microbiota variation in common laboratory mice
    • Hildebrand F, Nguyen TL, Brinkman B, Yunta RG, Cauwe B, Vandenabeele P, Liston A, Raes J. Inflammation-associated entero-types, host genotype cage and inter-individual effects drive gut microbiota variation in common laboratory mice. Genome Biol 2013;14:R4.
    • (2013) Genome Biol , vol.14 , pp. R4
    • Hildebrand, F.1    Nguyen, T.L.2    Brinkman, B.3    Yunta, R.G.4    Cauwe, B.5    Vandenabeele, P.6    Liston, A.7    Raes, J.8
  • 9
  • 10
    • 79952061363 scopus 로고    scopus 로고
    • Probiotics in inflammatory bowel diseases and associated conditions
    • Mack DR. Probiotics in inflammatory bowel diseases and associated conditions. Nutrients 2011;3:245-64.
    • (2011) Nutrients , vol.3 , pp. 245-264
    • Mack, D.R.1
  • 13
    • 79954526916 scopus 로고    scopus 로고
    • What is the optimal therapy for severe ulcerative colitis?
    • MacDermott RP, Green JA, Ashley CC. What is the optimal therapy for severe ulcerative colitis? Inflamm Bowel Dis 2008;14:S228-31.
    • (2008) Inflamm Bowel Dis , vol.14 , pp. S228-S231
    • Macdermott, R.P.1    Green, J.A.2    Ashley, C.C.3
  • 14
    • 59749088586 scopus 로고    scopus 로고
    • Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis
    • Miele E, Pascarella F, Giannetti E, Quaglietta L, Baldassano RN, Staiano A. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol 2009;104:437-43.
    • (2009) Am J Gastroenterol , vol.104 , pp. 437-443
    • Miele, E.1    Pascarella, F.2    Giannetti, E.3    Quaglietta, L.4    Baldassano, R.N.5    Staiano, A.6
  • 15
    • 66949177978 scopus 로고    scopus 로고
    • Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: A multicenter, randomized, double-blind, placebo-controlled study
    • Scherl EJ, Pruitt R, Gordon GL, Lamet M, Shaw A, Huang S, Mareya S, Forbes WP. Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study. Am J Gastroenterol 2009;104:1452-9.
    • (2009) Am J Gastroenterol , vol.104 , pp. 1452-1459
    • Scherl, E.J.1    Pruitt, R.2    Gordon, G.L.3    Lamet, M.4    Shaw, A.5    Huang, S.6    Mareya, S.7    Forbes, W.P.8
  • 16
    • 79960371715 scopus 로고    scopus 로고
    • Abnormal expansion of segmented filamentous bacteria in the gut: A role in pathogenesis of chronic inflammatory intestinal diseases?
    • Bellavia M, Damiano G, Gioviale MC, Palumbo VD, Cacciabaudo F, Buscemi G, Lo Monte AI. Abnormal expansion of segmented filamentous bacteria in the gut: a role in pathogenesis of chronic inflammatory intestinal diseases? Rev Microbiol 2011;22:45-7.
    • (2011) Rev Microbiol , vol.22 , pp. 45-47
    • Bellavia, M.1    Damiano, G.2    Gioviale, M.C.3    Palumbo, V.D.4    Cacciabaudo, F.5    Buscemi, G.6    Lo Monte, A.I.7
  • 17
    • 84856374012 scopus 로고    scopus 로고
    • From gut microflora imbalance to mycobacteria infection: Is there a relationship with chronic intestinal inflammatory diseases?
    • Tomasello G, Bellavia M, Palumbo VD, Gioviale MC, Damiani P, Lo Monte AI. From gut microflora imbalance to mycobacteria infection: is there a relationship with chronic intestinal inflammatory diseases? Ann Ital Chir 2011;82:361-8.
    • (2011) Ann Ital Chir , vol.82 , pp. 361-368
    • Tomasello, G.1    Bellavia, M.2    Palumbo, V.D.3    Gioviale, M.C.4    Damiani, P.5    Lo Monte, A.I.6
  • 22
    • 84912059418 scopus 로고    scopus 로고
    • Enteric micobiota leads to new therapeutic strategies for ulcerative colitis
    • Chen WX, Ren LH, Shi RH. Enteric micobiota leads to new therapeutic strategies for ulcerative colitis. World J Gastroenterol 2014;20:15657-63.
    • (2014) World J Gastroenterol , vol.20 , pp. 15657-15663
    • Chen, W.X.1    Ren, L.H.2    Shi, R.H.3
  • 23
    • 84924546208 scopus 로고    scopus 로고
    • The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: A systematic review of randomized human clinical trials
    • Saez-Lara MJ, Gomez-Llorente C, Plaza-Diaz J, Gil A. The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. Biomed Res Int 2015;2015:505878.
    • (2015) Biomed Res Int , pp. 2015
    • Saez-Lara, M.J.1    Gomez-Llorente, C.2    Plaza-Diaz, J.3    Gil, A.4
  • 27
    • 12244299541 scopus 로고    scopus 로고
    • Demonstration of functional properties of probiotic lactic acid bacteria
    • Collins JK. Demonstration of functional properties of probiotic lactic acid bacteria. Ind Latte 2001;37:39-61.
    • (2001) Ind Latte , vol.37 , pp. 39-61
    • Collins, J.K.1
  • 28
    • 7644231876 scopus 로고    scopus 로고
    • Anticancerogenic effect of a novel chiroinositol-containing polysaccharide from Bifidobacterium bifidum BGN4
    • You HJ, Oh DK, Ji GE. Anticancerogenic effect of a novel chiroinositol-containing polysaccharide from Bifidobacterium bifidum BGN4. FEMS Microbiol Lett 2004;240:131-6.
    • (2004) FEMS Microbiol Lett , vol.240 , pp. 131-136
    • You, H.J.1    Oh, D.K.2    Ji, G.E.3
  • 30
    • 0037309595 scopus 로고    scopus 로고
    • Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis
    • Ishikawa H, Akedo I, Umesaki Y, Tanaka R, Imaoka A, Otani T. Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J Am Coll Nutr 2003;22:56-63.
    • (2003) J am Coll Nutr , vol.22 , pp. 56-63
    • Ishikawa, H.1    Akedo, I.2    Umesaki, Y.3    Tanaka, R.4    Imaoka, A.5    Otani, T.6
  • 32
    • 79953069242 scopus 로고    scopus 로고
    • A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. Lactis BB-12 for maintenance of remission in ulcerative colitis
    • Wildt S, Nordgaard I, Hansen U, Brockmann E, Rumessen JJ. A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis. J Crohns Colitis 2011;5:115-21.
    • (2011) J Crohns Colitis , vol.5 , pp. 115-121
    • Wildt, S.1    Nordgaard, I.2    Hansen, U.3    Brockmann, E.4    Rumessen, J.J.5
  • 35
    • 77956563659 scopus 로고    scopus 로고
    • Effect of probiotics on pro-inflammatory cytokines and NF-κB activation in ulcerative colitis
    • Hegazy SK, El-Bedewy MM. Effect of probiotics on pro-inflammatory cytokines and NF-κB activation in ulcerative colitis. World J Gastroenterol 2010;16:4145-51.
    • (2010) World J Gastroenterol , vol.16 , pp. 4145-4151
    • Hegazy, S.K.1    El-Bedewy, M.M.2
  • 36
    • 84855355717 scopus 로고    scopus 로고
    • Randomised clinical trial: The effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis
    • Oliva S, Di Nardo G, Ferrari F, Mallardo S, Rossi P, Patrizi G, Cucchiara S, Stronati L. Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Aliment Pharmacol Ther 2012;35:327-34.
    • (2012) Aliment Pharmacol Ther , vol.35 , pp. 327-334
    • Oliva, S.1    Di Nardo, G.2    Ferrari, F.3    Mallardo, S.4    Rossi, P.5    Patrizi, G.6    Cucchiara, S.7    Stronati, L.8
  • 37
    • 79955636576 scopus 로고    scopus 로고
    • Rectal administration of Lactobacillus casei DG modifies flora composition and toll-like receptor expression in colonic mucosa of patients with mild ulcerative colitis
    • D’Incà R, Barollo M, Scarpa M, Grillo AR, Brun P, Vettorato MG, Castagliuolo I, Sturniolo GC. Rectal administration of Lactobacillus casei DG modifies flora composition and toll-like receptor expression in colonic mucosa of patients with mild ulcerative colitis. Dig Dis Sci 2011;56:1178-87.
    • (2011) Dig Dis Sci , vol.56 , pp. 1178-1187
    • D’Incà, R.1    Barollo, M.2    Scarpa, M.3    Grillo, A.R.4    Brun, P.5    Vettorato, M.G.6    Castagliuolo, I.7    Sturniolo, G.C.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.